Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $5,473 - $8,220
-83 Reduced 24.63%
254 $17.3 Million
Q2 2023

Aug 09, 2023

BUY
$62.68 - $95.05 $21,123 - $32,031
337 New
337 $31.5 Million
Q2 2022

Aug 09, 2023

BUY
$35.61 - $76.23 $12,000 - $25,689
337 New
337 $31.5 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Quintet Private Bank (Europe) S.A. Portfolio

Follow Quintet Private Bank (Europe) S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quintet Private Bank (Europe) S.A., based on Form 13F filings with the SEC.

News

Stay updated on Quintet Private Bank (Europe) S.A. with notifications on news.